Rising Threat: Long‐Term Trends in the Incidence and Mortality of Thymic Epithelial Tumor
Cancer Medicine · 2025
DOI: 10.1002/cam4.70968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Zishan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian…. Hauptthemen laut MEDLINE: Thymus Neoplasms, Neoplasms, Glandular and Epithelial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
An upward trend in the incidence of thymic epithelial tumors (TETs) has been reported over the past few decades, but because of its rarity, little is currently known about its epidemiological trends. This study examined temporal trends in the incidence and mortality of TETs in the US and explored these trends in population subgroups while investigating important factors that influence their prognosis.
Methods
A retrospective, population‐based study was conducted using nationally representative data from the Surveillance, Epidemiology, and End Results program, and 4979 patients diagnosed with TETs from 2000 to 2020 were evaluated. Associated population data were used to determine age‐adjusted incidence and mortality, and 5‐year TET‐specific mortality (SM). Trends were assessed for the entire cohort, as well as for particular subgroups, including thymoma and thymic carcinoma.
Results
From 2000 to 2020, the overall incidence and mortality of TETs were 2.769 and 1.203 per million person‐years, respectively. Both the age‐adjusted incidence and mortality of TETs increased over the study period, with increases occurring across almost all ethnic groups, histological subtypes, and stages. Multivariate analysis revealed that age, World Health Organization histological type (B1, B2, and B3 thymoma and thymic carcinoma), Masaoka–Koga stage (IIB and III/IV), maximum tumor diameter (5–10 and > 10 cm), surgery, and chemotherapy were independently associated with TET‐SM.
Conclusions
The incidence and mortality of TETs have steadily increased over time, and these trends might be related to the widespread use of computed tomography for lung cancer screening and the increasing number of TETs found incidentally. The study also identified several important factors independently associated with TET‐SM, suggesting that early diagnosis and surgical intervention are critical to achieving good prognoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
ORCID-Profile: Fei He
Zitieren
APA
Chen, Z., Liu, S., Chen, C., Zhuang, J., Xu, X., Liu, M., Lai, F., & He, F. (2025). Rising Threat: Long‐Term Trends in the Incidence and Mortality of Thymic Epithelial Tumor. Cancer Medicine. https://doi.org/10.1002/cam4.70968
Vancouver
Chen Z, Liu S, Chen C, Zhuang J, Xu X, Liu M, et al. Rising Threat: Long‐Term Trends in the Incidence and Mortality of Thymic Epithelial Tumor. Cancer Medicine. 2025. doi:10.1002/cam4.70968
BibTeX
@article{Chen2025,
author = {Chen, Zishan and Liu, Shiwen and Chen, Chunting and Zhuang, Jinmang and Xu, Xinying and Liu, Maolin and Lai, Fancai and He, Fei},
title = {Rising Threat: Long‐Term Trends in the Incidence and Mortality of Thymic Epithelial Tumor},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70968}
}
EUVIMED